. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2013 Dec 18;90(0):69–75. doi: 10.1016/j.plefa.2013.12.003

Table 1.

Baseline Data by Group [mean (SD) unless otherwise noted]

	Healthy Controls	Insulin Resistant Subjects

Variable	n=14	n=61
Age (years)	44.9 (12.3)	47.7 (10.3)
Sex male, n (%)	9 (64.3)	36 (59.0)
BMI (kg/m²)	22.9 (1.2)	32.3 (4.0)^c
Systolic BP (mmHg)	112.4 (8.8)	132.2 (11.5)^c
Diastolic BP (mmHg)	68.7 (6.6)	82.7 (7.4)^c
Triacylglycerols (mg/dL)	76.4 (22.4)	213.0 (81.6)^c
Total Cholesterol (mg/dL)	181.2 (30.0)	203.1 (43.2)
HDL-C (mg/dL)	55.9 (8.6)	41.7 (8.3)^c
Non-HDL-C (mg/dL)	125.3 (28.1)	161.6 (39.7)^b
Glucose (mg/dL)	88.2 (9)	100.8 (10.8)^c
Insulin (uU/mL)	3.2 (1.5)	14.0 (8.4)^c
HOMA-IR	0.7 (0.3)	3.5 (2.2)^c
Current Smoker, n (%)	0 (0)	5 (8.2)
Current statin use, n (%)	0 (0)	8 (13.1)
LA (% total)
HDL fraction	25.4 (3.8)	24.1 (4.2)
LDL fraction	29.8 (5.4)	29.3 (4.6)
VLDL fraction	15.4 (3.5)	20.1 (3.4)^b
Plasma fraction	29.6 (0.2)	27.5 (4.3)
AA (% total)
HDL fraction	10.3 (1.7)	11.5 (2.7)^a
LDL fraction	7.3 (1.5)	8.5 (1.9)^a
VLDL fraction	3.7 (0.8)	5.6 (1.6)^b
Plasma fraction	8.0 (1.4)	7.4 (1.8)
EPA (% total)
HDL fraction	0.8 (0.4)	0.6 (0.3)
LDL fraction	0.7 (0.4)	0.5 (0.3)
VLDL fraction	0.3 (0.2)	0.3 (0.2)
Plasma fraction	0.8 (0.6)	0.4 (0.2)^a
DHA (% total)
HDL fraction	2.8 (1.0)	2.3 (0.6)
LDL fraction	1.8 (0.7)	1.5 (0.4)
VLDL fraction	1.1 (0.7)	1.3 (0.5)
Plasma fraction	2.1 (0.9)	1.4 (0.4)^a
DPA (% total)
HDL fraction	0.8 (0.2)	0.8 (0.2)
LDL fraction	0.5 (0.2)	0.5 (0.1)
VLDL fraction	0.4 (0.1)	0.5 (0.1)^a
Plasma fraction	0.6 (0.2)	0.5 (0.1)

p<0.05,

p<0.01,

p<0.001 when control was compared to healthy controls HOMA-IR, homeostatic model assessment of insulin resistance; LA, linoleic acid; AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid